Nuñez, Baby Boy B.
HRN: 24-19-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/13/2023
12/20/2023
IV
LD 38 Mg, Maintain At 19mg
Q8
T/c Neonatal Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes